Operating EBITDA increased by 13 per cent to Rs 305 crores
JB Pharma posted Q3 FY26 results. The company registered revenue of Rs 1065 crores in Q3 FY26 (YoY growth of 11 per cent) and Rs 3244 crores in 9M FY26 (YoY growth of 9 per cent). Domestic formulations business recorded revenue of Rs 620 crores vs Rs 566 crores (YoY growth of 10 per cent). International business revenue grew by 12 per cent to Rs 445 crores vs Rs 398 crores. Domestic and CDMO business revenue combined constitutes 70 per cent of overall revenue for 9M FY26.
Operating EBITDA was Rs 305 crores in Q3 FY26 (YoY growth of 13 per cent) and Rs 955 crores in 9M FY26 (YoY growth of 13 per cent). Operating EBITDA margin improved to 28.7 per cent for Q3 FY26 YoY and improved to 29.4 per cent for 9M FY26 YoY.
Gross margins were at 69.1 per cent for Q3 FY26 improving by 200 bps as compared to Q3 FY25. Gross margins for 9M FY26 was at 68.5 per cent as compared to 66.5 per cent for 9M FY25. Gross margins improved due to better product mix, stable RM prices and positive price growth. Other income increased to Rs 18 crores for Q3 FY26 as compared to Rs 8 crores in Q3 FY25 on account of treasury income. Depreciation expenses for Q3 FY26 increased to Rs 45 crores Vs Q3 FY25 at Rs 42 crores.
The net profit improved by 22 per cent YoY to Rs 198 crores for Q3 FY26 vs Rs 162 crores for Q3 FY25.
Domestic business continued its momentum and registered YoY growth of 10 per cent to Rs 620 crores for Q3 FY26. Domestic business constitutes 60 per cent of overall turnover in 9M FY26 as compared to 59 per cent of revenue in 9M FY25.
International business revenue grew at 12 per cent to Rs 445 crores for Q3 FY26. International formulations business grew by 20 per cent to Rs 306 crores for Q3 FY26. All the exports businesses viz. South Africa, Russia, the US and branded exports markets performed well for the quarter. The CDMO business revenue remained nearly flat at Rs 117 crores for Q3 FY26. Despite high base in Q3 FY25, CDMO business sales momentum sustained in this quarter.
